跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Saatin 20 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Saatin 20
Approved
STANDARD
Saatin 20
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
53d4bd680ddbae68
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
53d4bd680ddbae68
Drug Approval Philippines Name
Saatin 20
Product Name
Saatin 20
Registration Number
DRP-5155-01
Brand Name
Saatin 20
Generic Name
Atorvastatin (As Calcium)
Dosage Form
Film-Coated Tablet
Dosage Strength
20 mg
Manufacturer
Hizon Laboratories, Inc.
Distributor
GX International, Inc.
Issuance Date
27 July 2023
Expiry Date
02 September 2028
Pharmacologic Category
Antihyperlipidemic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
53d4bd680ddbae68
Type
Standard
Back to Philippines FDA Approvals